Performance of the pooled cohort equations and D:A:D risk scores among individuals with HIV in a global cardiovascular disease prevention trial: a cohort study leveraging data from REPRIEVE
Steven Grinspoon(Massachusetts General Hospital), Pamela S. Douglas(Duke University), Carl J. Fichtenbaum(Cancer Research And Biostatistics), Sarah M Chu(Harvard University), Virginia A. Triant(Brigham and Women's Hospital), Lori E. Fantry(University of Maryland, Baltimore), Mireia de la Peña(Hospital de Basurto), Amy Kantor(Cancer Research And Biostatistics), Michael T. Lu(Cancer Research And Biostatistics), Triin Umbleja(Harvard University), Carlos Malvestutto(The Ohio State University Wexner Medical Center), Edward M. Gardner(Denver Public Health), Gerald S. Bloomfield, Marissa R Diggs(Harvard University), Judith S. Currier(University of California, Los Angeles), Kathleen V. Fitch(Harvard University), Judith A. Aberg(Icahn School of Medicine at Mount Sinai), Markella V. Zanni(Harvard University), José L. Casado(Instituto Cajal), Heather J. Ribaudo(Cancer Research And Biostatistics)
Cited by 32
Related Papers
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
|New England Journal of Medicine|2010|7.2k
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: Executive Summary
|Circulation|2012|2.4k
Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement
|New England Journal of Medicine|2012|2.3k